Patent · US Active

Compounds and uses thereof

US10780074B2 · kind B2 · utility

1Cited by
62References
55Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 1, 2018
Grant dateSep 22, 2020
Priority date
Expiry dateAug 1, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I are described as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.